Mutation-counting blood test could predict if cutting-edge immunotherapies can beat a cancer By Ken GarberJun. 27, 2018
A promising new cancer drug has hit a major setback, raising questions about whether the field is moving too fast By Ken GarberMay. 9, 2018
